BioSyntech, Inc.
BSYI
$0.00
$0.000.00%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | 1.13% | -17.45% | -22.56% | -26.61% | -31.02% |
| Total Depreciation and Amortization | -20.20% | -30.40% | -29.89% | -19.11% | -18.50% |
| Total Amortization of Deferred Charges | -38.26% | -40.03% | -35.40% | -27.77% | -6.05% |
| Total Other Non-Cash Items | 212.82% | 435.06% | 1,738.34% | 830.56% | 319.57% |
| Change in Net Operating Assets | -955.52% | -402.50% | -319.03% | -661.72% | -55.41% |
| Cash from Operations | 24.38% | 8.12% | -5.40% | -5.12% | -21.94% |
| Capital Expenditure | 96.39% | 90.65% | -67.51% | -85.22% | -98.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.71% | -99.35% | -99.52% | -99.57% | -28.13% |
| Cash from Investing | -99.01% | -99.88% | -102.56% | -102.44% | -33.63% |
| Total Debt Issued | -64.14% | -88.84% | -- | -- | 527.50% |
| Total Debt Repaid | -11.42% | -10.93% | -10.48% | -3.61% | 81.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.38% | 77.65% | -2,173.81% | -7,153.94% | -1,422.77% |
| Cash from Financing | -73.01% | -95.18% | 1,799.54% | 1,926.59% | 1,103.29% |
| Foreign Exchange rate Adjustments | 19.05% | 728.57% | 6,800.00% | 7,200.00% | 887.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -212.00% | -206.44% | 207.25% | 259.90% | 171.02% |
